MEDPMedpace Holdings, Inc.
What is the market doing?
No clear lean: nothing decisive, though in an uptrend.
In an uptrend, above its rising 50- and 200-day averages. Price is +17% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 8, 2026; selling is often routine (taxes, diversification).
Moderately shorted, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How MEDP is trading
Medpace Holdings, Inc. is +23% over the past year while the S&P 500 is +18%: 4.5 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +17%
vs 200-day average · a clear uptrend
- RSI (14)
- 45
RSI (14) · neutral
- Below its 52-week high
- 2.9%
Below its 52-week high
Details›
- Last close2026-10-09
- $612.15
- 1 monthS&P 500 +2.7%
- +5.0%
- 1 yearS&P 500 +18%
- +23%
- 5 yearsS&P 500 +88%
- +238%
- vs 50-day average$601.96
- +1.7%
- 52-week high
- $630.21
- 52-week low
- $393.42
- Annualised volatility
- 57%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$216M
| Year | Return |
|---|---|
| 2026 (year to date) | +9.0% |
| 2025 | +69% |
| 2024 | +8.4% |
| 2023 | +44% |
| 2022 | −2.4% |
| 2021 | +56% |
| 2020 | +66% |
| 2019 | +59% |
| 2018 | +46% |
| 2017 | +0.53% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 6 of 10 | +0.64% |
| Feb | 10 | 3 of 10 | −3.5% |
| Mar | 10 | 7 of 10 | +0.69% |
| Apr | 10 | 6 of 10 | −0.77% |
| May | 10 | 5 of 10 | +2.5% |
| Jun | 10 | 10 of 10 | +8.3% |
| Jul | 10 | 7 of 10 | +14% |
| Aug | 10 | 7 of 10 | +3.4% |
| Sep | 11 | 7 of 11 | +0.06% |
| Oct | 11 | 5 of 11 | +5.1% |
| Nov | 10 | 7 of 10 | +5.8% |
| Dec | 10 | 7 of 10 | +2.5% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Diagnostics & Research
Ranks #1 of 21 by RyuScore